Panacea Biotec Pharma Limited Malpur, Baddi

Form 483 issued October 12, 2023 · Solan, India

Inspection
Oct 3 – Oct 12, 2023
Observations
1
Pages
8
FEI number
3007187282

In short: On October 12, 2023, FDA issued a Form 483 with 1 observation to Panacea Biotec Pharma Limited Malpur, Baddi in Solan, India (FEI 3007187282) after an inspection that ran Oct 3 – Oct 12, 2023. The investigators were Muna Algharibeh and Sandra A. Boyd. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Panacea Biotec Pharma Limited Malpur, Baddi?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Panacea Biotec Pharma Limited Malpur, Baddi?

Muna Algharibeh and Sandra A. Boyd are named on this Form 483, for the inspection of Oct 3 – Oct 12, 2023. Each investigator has a profile showing what they cite most.

When was Panacea Biotec Pharma Limited Malpur, Baddi inspected by FDA?

The inspection ran Oct 3 – Oct 12, 2023, and the Form 483 is dated October 12, 2023.

How do I get the full Form 483 for Panacea Biotec Pharma Limited Malpur, Baddi?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free